Christopher Sweeney

Phase 1 clinical trial of the novel proteasome inhibitor marizomib with the histone deacetylase inhibitor vorinostat in patients with melanoma, pancreatic and lung cancer based on in vitro assessments of the combination

Michael Millward, Timothy Price, Amanda Townsend et al. · Investigational New Drugs · 2011 · 149 citations

Medicine, Oncology, Pharmacology +14

Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer

Felix Y. Feng, Huei–Chung Huang, Daniel E. Spratt et al. · JAMA Oncology · 2021 · 148 citations · Full text

Medicine, Oncology, Urology +17

Updated overall survival outcomes in ENZAMET (ANZUP 1304), an international, cooperative group trial of enzalutamide in metastatic hormone-sensitive prostate cancer (mHSPC).

Ian D. Davis, Andrew Martin, Robert Zielinski et al. · Journal of Clinical Oncology · 2022 · 53 citations

Medicine, Oncology, Pharmacotherapy +17

Impact on overall survival (OS) with chemohormonal therapy versus hormonal therapy for hormone-sensitive newly metastatic prostate cancer (mPrCa): An ECOG-led phase III randomized trial.

Christopher Sweeney, Yu‐Hui Chen, Michael A. Carducci et al. · Journal of Clinical Oncology · 2014 · 51 citations

Medicine, Oncology, Pharmacology +17

Interventional vitamin C: A strategy for attenuation of coagulopathy and inflammation in a swine multiple injuries model

Penny S. Reynolds, Bernard Fisher, Jacquelyn McCarter et al. · The Journal of Trauma: Injury, Infection, and Critical Care · 2018 · 26 citations

Veterinary Medicine, Veterinary Pharmacology, Veterinary Physiology +17